Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionAvidian Wealth Solutions, LLC
Latest Disclosed Ownership25,711 shares
Latest Disclosed Value $ 2,639,732
Avidian Wealth Solutions, LLC reports 162.49% increase in ownership of ABL / Abbott Laboratories

On May 7, 2026 - Avidian Wealth Solutions, LLC filed a 13F-HR form disclosing ownership of 25,711 shares of Abbott Laboratories (DE:ABL) valued at $2,283,651 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 9,795 shares of Abbott Laboratories. This represents a change in shares of 162.49% during the quarter. The current value of the position is $1,933,981 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 25,711 15,916 162.49 2,640 115.08 0.0835
2026-02-02 2025-12-31 13F ABBOTT LABS COM 002824100 9,795 494 5.31 1,227 -1.45 0.0447
2025-10-30 2025-09-30 13F ABBOTT LABS COM 002824100 9,301 517 5.89 1,246 4.27 0.0469
2025-07-30 2025-06-30 13F ABBOTT LABS COM 002824100 8,784 -252 -2.79 1,195 -0.33 0.0486
2025-04-25 2025-03-31 13F ABBOTT LABS COM 002824100 9,036 337 3.87 1,199 21.87 0.0534
2025-01-29 2024-12-31 13F ABBOTT LABS COM 002824100 8,699 486 5.92 984 5.02 0.0442
2024-10-30 2024-09-30 13F ABBOTT LABS COM 002824100 8,213 157 1.95 936 11.83 0.0425
2024-08-06 2024-06-30 13F ABBOTT LABS COM 002824100 8,056 -1,789 -18.17 837 -25.13 0.0348
2024-05-03 2024-03-31 13F ABBOTT LABS COM 002824100 9,845 752 8.27 1,119 11.80 0.0543
2024-02-06 2023-12-31 13F ABBOTT LABS COM 002824100 9,093 -134 -1.45 1,001 11.98 0.0616
2023-10-13 2023-09-30 13F ABBOTT LABS COM 002824100 9,227 -815 -8.12 894 -18.37 0.0629
2023-08-03 2023-06-30 13F ABBOTT LABS COM 002824100 10,042 -36,157 -78.26 1,095 -76.61 0.0717
2023-05-08 2023-03-31 13F ABBOTT LABS COM 002824100 46,199 1,544 3.46 4,678 -4.57 0.2566
2023-02-06 2022-12-31 13F ABBOTT LABS COM 002824100 44,655 9,519 27.09 4,903 44.18 0.3193
2022-11-03 2022-09-30 13F ABBOTT LABS COM 002824100 35,136 34 0.10 3,400 -10.85 0.2457
2022-07-29 2022-06-30 13F ABBOTT LABS COM 002824100 35,102 2,196 6.67 3,814 -2.08 0.2699
2022-05-10 2022-03-31 13F ABBOTT LABS COM 002824100 32,906 -616 -1.84 3,895 -17.44 0.2386
2022-02-14 2021-12-31 13F ABBOTT LABS COM 002824100 33,522 516 1.56 4,718 21.01 0.2937
2021-11-10 2021-09-30 13F ABBOTT LABS COM 002824100 33,006 467 1.44 3,899 3.37 0.2970
2021-08-09 2021-06-30 13F ABBOTT LABS COM 002824100 32,539 1,182 3.77 3,772 0.37 0.2894
2021-05-05 2021-03-31 13F ABBOTT LABS COM 002824100 31,357 -97 -0.31 3,758 9.12 0.3202
2021-02-09 2020-12-31 13F ABBOTT LABS COM 002824100 31,454 -4,351 -12.15 3,444 -11.62 0.3265
2021-02-03 2020-09-30 13F/A-1 ABBOTT LABS COM 002824100 35,805 6,381 21.69 3,897 44.87 0.4415
2020-11-06 2020-09-30 13F ABBOTT LABS COM 002824100 35,805 6,381 3,897 902,639.1250
2020-08-10 2020-06-30 13F ABBOTT LABS COM 002824100 29,424 520 1.80 2,690 17.93 0.3629
2020-04-22 2020-03-31 13F ABBOTT LABS COM 002824100 28,904 17,587 155.40 2,281 132.04 0.3660
2020-02-13 2019-12-31 13F ABBOTT LABS COM 002824100 11,317 2,020 21.73 983 26.35 0.1397
2019-11-14 2019-09-30 13F ABBOTT LABS COM 002824100 9,297 1,836 24.61 778 24.08 0.1281
2019-08-14 2019-06-30 13F ABBOTT LABS COM 002824100 7,461 156 2.14 627 7.36 0.1482
2019-05-15 2019-03-31 13F ABBOTT LABS COM 002824100 7,305 0 0.00 584 10.61 0.1298
2019-02-14 2018-12-31 13F ABBOTT LABS COM 002824100 7,305 4,003 121.23 528 118.18 0.1843
2018-11-14 2018-09-30 13F ABBOTT LABS COM 002824100 3,302 -2,173 -39.69 242 -27.54 0.0757
2018-08-14 2018-06-30 13F ABBOTT LABS COM 002824100 5,475 0 0.00 334 1.83 0.1054
2018-05-15 2018-03-31 13F ABBOTT LABS COM 002824100 5,475 155 2.91 328 7.89 0.1099
2018-02-14 2017-12-31 13F ABBOTT LABS COM 002824100 5,320 200 3.91 304 11.36 0.0813
2017-11-14 2017-09-30 13F ABBOTT LABS COM 002824100 5,120 -66 -1.27 273 8.33 0.1040
2017-08-14 2017-06-30 13F ABBOTT LABS COM 002824100 5,186 66 1.29 252 11.01 0.1047
2017-05-15 2017-03-31 13F ABBOTT LABS COM 002824100 5,120 5,120 227 0.0870
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.